BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16738405)

  • 1. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.
    Bor YC; Swartz J; Morrison A; Rekosh D; Ladomery M; Hammarskjöld ML
    Genes Dev; 2006 Jun; 20(12):1597-608. PubMed ID: 16738405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.
    Li H; Hou S; Hao T; Azam S; Liu C; Shi L; Lei H
    RNA Biol; 2015; 12(12):1364-71. PubMed ID: 26512748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C; Romaniuk PJ
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
    Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
    Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
    Ullmark T; Montano G; Gullberg U
    Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
    Oji Y; Tatsumi N; Kobayashi J; Fukuda M; Ueda T; Nakano E; Saito C; Shibata S; Sumikawa M; Fukushima H; Saito A; Hojo N; Suzuki M; Hoshikawa T; Shimura T; Morii E; Oka Y; Hosen N; Komatsu K; Sugiyama H
    Mol Carcinog; 2015 Dec; 54(12):1758-71. PubMed ID: 25418835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.
    Tatsumi N; Hojo N; Sakamoto H; Inaba R; Moriguchi N; Matsuno K; Fukuda M; Matsumura A; Hayashi S; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Sugiyama H; Oji Y
    PLoS One; 2015; 10(6):e0130578. PubMed ID: 26090994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes.
    Niksic M; Slight J; Sanford JR; Caceres JF; Hastie ND
    Hum Mol Genet; 2004 Feb; 13(4):463-71. PubMed ID: 14681305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor protein (-KTS) modulates renin gene transcription.
    Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
    Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.
    Nishikawa T; Wojciak JM; Dyson HJ; Wright PE
    Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [WT1 gene expression and its isoform ratio in different cell subsets of normal human bone marrow].
    Xu J; Wang HW; Li XH; Zhu L; Zhang L; Zhang F; Tan YH; Yang T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):603-6. PubMed ID: 17605875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
    Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes.
    Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA
    Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intron with a constitutive transport element is retained in a Tap messenger RNA.
    Li Y; Bor YC; Misawa Y; Xue Y; Rekosh D; Hammarskjöld ML
    Nature; 2006 Sep; 443(7108):234-7. PubMed ID: 16971948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wilms tumor gene (WT1) (+/-KTS) isoforms regulate steroidogenesis by modulating the PI3K/AKT and ERK1/2 pathways in bovine granulosa cells†.
    Meng K; Wang X; He Y; Yang J; Wang H; Zhang Y; Quan F
    Biol Reprod; 2019 May; 100(5):1344-1355. PubMed ID: 30649196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
    Laity JH; Chung J; Dyson HJ; Wright PE
    Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
    Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
    Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.